| 672448 |
FRONTIERS IN ONCOLOGY |
Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma |
2021-04-01 |
10.3389/fonc.2021.587479 |
Zhang Tao, Nie Yingli, Gu Jian, Cai Kailin, Chen Xiangdong, Li Huili, Wang Jiliang |
| 672447 |
FRONTIERS IN ONCOLOGY |
Akt Inhibition Enhanced the Growth Inhibition Effects of Low-Dose Heavy-Ion Radiation via the PI3K/Akt/p53 Signaling Pathway in C6 Glioblastoma Cells |
2021-04-01 |
10.3389/fonc.2021.649176 |
Huang Ke, Zhao Wei, Wang Xuqiao, Qiu Yingfei, Liu Zelin, Chen Rui, Liu Wei, Liu Bin |
| 672446 |
FRONTIERS IN ONCOLOGY |
Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma |
2021-04-01 |
10.3389/fonc.2021.591507 |
Sun Rui, Li Simin, Zhao Ke, Diao Mei, Li Long |
| 672445 |
FRONTIERS IN ONCOLOGY |
Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer |
2021-04-01 |
10.3389/fonc.2021.647236 |
Wan Jiaming, Guo Cheng, Fang Hongpeng, Xu Zhongye, Hu Yongwei, Luo Yun |
| 672444 |
FRONTIERS IN ONCOLOGY |
Safety and Activity of Programmed Cell Death 1 Versus Programmed Cell Death Ligand 1 Inhibitors for Platinum-Resistant Urothelial Cancer: A Meta-Analysis of Published Clinical Trials |
2021-04-01 |
10.3389/fonc.2021.629646 |
Li Zaishang, Li Xueying, Lam Wayne, Cao Yabing, Han Hui, Zhang Xueqi, Fang Jiequn, Xiao Kefeng, Zhou Fangjian |
| 672443 |
FRONTIERS IN ONCOLOGY |
Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer |
2021-04-01 |
10.3389/fonc.2021.642544 |
Ewig Celeste L. Y., Cheng Yi Man, Li Hoi Shan, Wong Jasper Chak Ling, Cho Alex Hong Yu, Poon Freddie Man Hong, Li Chi Kong, Cheung Yin Ting |
| 672442 |
FRONTIERS IN ONCOLOGY |
Strategies for Dodging the Obstacles in CAR T Cell Therapy |
2021-04-01 |
10.3389/fonc.2021.627549 |
Safarzadeh Kozani Pooria, Safarzadeh Kozani Pouya, Rahbarizadeh Fatemeh, Khoshtinat Nikkhoi Shahryar |
| 672441 |
FRONTIERS IN ONCOLOGY |
Radiographic Features and Clinical Factor for Preoperative Prediction in the Bulging Duodenal Papilla With Malignancy |
2021-04-01 |
10.3389/fonc.2021.627482 |
Wang Xiao-Jie, Ke Jun-Li, Xu Jian-Xia, Zhou Jia-Ping, Lu Yuan-Fei, Zhou Qiao-Mei, Shi Dan, Yu Ri-Sheng |
| 672440 |
FRONTIERS IN ONCOLOGY |
Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
2021-04-01 |
10.3389/fonc.2021.642719 |
Behrooz Amir Barzegar, Syahir Amir |
| 672439 |
FRONTIERS IN ONCOLOGY |
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy |
2021-04-01 |
10.3389/fonc.2021.646883 |
Loosen Sven H., Gorgulho Joao, Jördens Markus S., Schulze-Hagen Maximilian, Beier Fabian, Vucur Mihael, Schneider Anne T., Koppe Christiane, Mertens Alexander, Kather Jakob N., Tacke Frank, Keitel Verena, Brümmendorf Tim H., Roderburg Christoph, Luedde Tom |
